Tetroxoprim

Drugbox
IUPAC_name = 5- [3,5-dimethoxy-4-(2-methoxyethoxy)benzyl] pyrimidine-2,4-diamine

---

CAS_number = 53808-87-0
CAS_supplemental =
ATC_prefix = J01
ATC_suffix = EE06
ATC_supplemental = (with sulfadiazine)
PubChem = 65450
DrugBank =
chemical_formula =
C=16 | H=22 | N=4 | O=4
molecular_weight = 334.70 g/mol
smiles = COCCOC1=C(C=C(C=C1OC)CC2=CN=C(N=C2N)N)OC
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration =

Tetroxoprim (INN) is a derivative of trimethoprim. It was first described in 1979. [cite journal |author=Aschhoff HS, Vergin H |title=Tetroxoprim—a new inhibitor of bacterial dihydrofolate reductase |journal=J Antimicrob Chemother |volume=5 |issue=B |pages=19–25 |year=1979 |month=November |pmid=43863 |doi= |url=]

References